Xenetic Reports First Patient Dosed in DNase — CAR T Combination Study for Large B — Cell Lymphoma
Xenetic Biosciences announced the first patient was dosed in a study combining systemic DNase with CAR T-cell therapy for large B-cell lymphoma. The 12-patient study at Tel Aviv Sourasky University Medical Center marks the technology’s first clinical evaluation alongside CAR T-cell therapy. Researchers will assess whet